文献速递神经免疫认知障碍与痴呆

小细胞肺癌的不同遗传特征塑造抗GABAB受体与抗Hu副肿瘤神经综合征

Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABAB R and Anti-Hu Paraneoplastic Neurological Syndromes.
PubMed 文献 · Ann Neurol · 2023-09-18

研究收集76例小细胞肺癌(SCLC)样本,其中抗Hu 34例、抗GABAB R 14例、无副肿瘤神经综合征(PNS)28例,进行靶向测序、拷贝数变异和全转录组RNA测序。结果显示抗GABAB R PNS患者常见5q染色体获得(含KCTD16),而抗Hu及对照常见缺失;转录组可区分三组,抗GABAB R组KCTD16过表达且富集B细胞特征,抗Hu组富集T细胞及干扰素-γ相关特征。

要点

  • 抗GABAB R PNS的SCLC常见5q染色体获得(含KCTD16),抗Hu及无PNS者常见缺失。
  • 转录组差异表达基因可将样本有效聚类为3组,与抗体分类对应。
  • 抗GABAB R脑炎肿瘤富集B细胞特征,抗Hu肿瘤过表达T细胞及干扰素-γ相关特征。

核心结论

  • SCLC的遗传和转录组特征可区分抗GABAB R、抗Hu及无PNS肿瘤。
  • KCTD16似乎在抗GABAB R PNS的肿瘤免疫耐受破坏中起关键作用。

研究设计与样本

  • 共收集76例SCLC肿瘤样本:抗Hu 34例、抗GABAB R 14例、无PNS 28例。
  • 研究包括4步:病理确认;使用包含98个基因(含编码自身抗体靶点ELAVL1-4、GABBR1-2和KCTD16的基因)的panel进行下一代测序;全基因组拷贝数变异(CNV)分析;全转录组RNA测序。

主要发现

  • CNV分析显示抗GABAB R PNS患者常见5q染色体获得(该区域包含KCTD16),而抗Hu和对照患者常携带缺失。
  • 未观察到任何肿瘤神经基因的突变数量有显著差异。
  • 转录组谱不同,差异表达基因可将样本有效聚类为3组,反映基于抗体的分类,其中KCTD16过表达为抗GABAB R PNS特有。
  • 通路分析显示抗GABAB R脑炎患者肿瘤富集B细胞特征,而抗Hu患者肿瘤过表达T细胞和干扰素-γ相关特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Small-cell lung cancer (SCLC) is the malignancy most frequently associated with paraneoplastic neurological syndromes (PNS) and can trigger different antibody responses against intracellular (Hu) or neuronal surface (GABAB R) antigens. Our aim was to clarify whether the genomic and transcriptomic features of SCLC are different in patients with anti-GABAB R or anti-Hu PNS compared with SCLC without PNS. METHODS: A total of 76 SCLC tumor samples were collected: 34 anti-Hu, 14 anti-GABAB R, and 28 SCLC without PNS. The study consisted of 4 steps: (1) pathological confirmation; (2) next generation sequencing using a panel of 98 genes, including those encoding the autoantibodies targets ELAVL1-4, GABBR1-2, and KCTD16; (3) genome-wide copy number variation (CNV); and (4) whole-transcriptome RNA sequencing. RESULTS: CNV analysis revealed that patients with anti-GABAB R PNS commonly have a gain in chromosome 5q, which contains KCTD16, whereas anti-Hu and control patients often harbor a loss. No significantly different number of mutations regarding any onconeural genes was observed. Conversely, the transcriptomic profile of SCLC was different, and the differentially expressed genes allowed effective clustering of the samples into 3 groups, reflecting the antibody-based classification, with an overexpression of KCTD16 specific to anti-GABAB R PNS. Pathway analysis revealed that tumors of patients with anti-GABAB R encephalitis were enriched in B-cell signatures, as opposed to those of patients with anti-Hu, in which T-cell- and interferon-γ-related signatures were overexpressed. INTERPRETATION: SCLC genetic and transcriptomic features differentiate anti-GABAB R, anti-Hu, and non-PNS tumors. The role of KCTD16 appears to be pivotal in the tumor immune tolerance breakdown of anti-GABAB R PNS. ANN NEUROL 2023;94:1102-1115.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Vogrig A, Pegat A, Villagrán-García M, et al. Different Genetic Signatures of Small-Cell Lung Cancer Characterize Anti-GABAB R and Anti-Hu Paraneoplastic Neurological Syndromes. Ann Neurol. 2023. PMID: 37638563. doi:10.1002/ana.26784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。